Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LICI
NCT00093301Phase 3Unknown
- Sponsor
- Wentworth Area Health Service
- Start
- Oct 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of levosimendan in cardiogenic shock, septic shock, sponsored by Wentworth Area Health Service. Status: unknown.
02
Drugs
levosimendan
03
Conditions
cardiogenic shockseptic shock
Beyond the preview
Go deeper on NCT00093301.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00093301.